Summary
Integrin αIIbβ3 is the key receptor regulating platelet retraction and accumulation and a proven drug-target for antithrombotic therapies. Here we resolve the cryoEM structures of the full-length αIIbβ3, which covers three distinct states along the activation pathway. Firstly, we obtain the αIIbβ3 structure at 3Å resolution in the inactive state, revealing the overall topology of the heterodimer with the transmembrane (TM) helices and the ligand-binding domain tucked in a specific angle proximity to the TM region. After the addition of a Mn2+ agonist, we resolve two coexisting structures representing two new states between inactive and active state. Our structures show conformational changes of the αIIbβ3 activating trajectory and a unique twisting of the integrin legs, which is required for platelets accumulation. Our structure provides direct structural evidence for how the lower legs are involved in full-length integrin activation mechanisms and offers a new strategy to target the αIIbβ3 lower leg.
Graphical Abstract
eTOC Blurb
Tong et al. determine the cryo-EM structures of full-length integrin αIIbβ3 in different states, which facilitates the understanding of the activation mechanism of the integrin αIIbβ3.
Introduction
Platelets are fundamental to preventing hemorrhaging at sites of vascular injuries through hemostasis, a healthy response to injury intended to stop and prevent further bleeding. However, their functions are tightly controlled since abnormal thrombosis can cause life-threatening health problems when a clot obstructs blood flow through healthy blood vessels in the circulatory system.1 Integrins are a major family of cell surface receptors which are essential to platelet activation.2–6 Integrins are multifunctional, since they mediate the adhesion of cells to the extracellular matrix and to other cells and participate intracellular and extracellular signaling in diverse cellular processes .5–8
αIIbβ3 is the major integrin expressed on platelets.5,6 Both the αIIb and β3 protomers are single-pass transmembrane proteins,8 (also known as a bitopic protein) each with a short cytoplasmic tail and a large extracellular domain responsible for heterodimer and ligand interactions. Integrin αIIbβ3 plays an integral role in thrombosis.9,10 Functionally, integrin αIIbβ3 transmits bidirectional signals across the cell membrane, in both “outside-in” and “inside-out” directions.11 Upon receiving extracellular or intracellular signals, αIIbβ3 undergoes conformational changes to achieve an activated state. The activated αIIbβ3 serves as one of the key elements in platelet activation and thus plays a pivotal role in thrombosis.12 αIIbβ3 direct involvement in the regulation of thrombosis makes it an appealing target for therapeutic strategy development.
Prior structural studies on integrin αIIbβ3 and its homologs have focused on individual regions namely the ectodomain and the headpiece.13–16 The flexibility of the linkers between the ectodomain and transmembrane domain has posed challenges in elucidating certain aspects of the full-length structure. Specifically, details regarding the connection between the ectodomain and transmembrane (TM) domain, as well as the overall orientation of the integrin on the cell membrane, have remained elusive. This limitation has constrained our comprehensive understanding of the precise arrangement of each domain in relation to one another. The orientations between the ectodomain and the TM helices are fundamental to fully understanding the integrin conformational changes on the cell surface. Such knowledge will provide crucial insights into the mechanism of ligand binding modulation and of coupling between extra- and intra-cellular domains, which allows the signal to be transduced across the membrane. In the process of signal transduction, integrins need to undergo a conformational transition from a bent form to an open form. Previous research has discovered that integrin αIIbβ3 in nanodisc had four states during the activation process induced by RGD peptide, which demonstrates the conformational change from a bent form to an upright form.17 It was also proposed that Mn2+ can activate the integrins by perturbing the conformation of the extracellular domains and thus mimic the signaling process.18–20 Several intermediate states between bent and open form were found based on the addition of Mn2+ by using SAXS or crystallography.21,22 However, previous studies on the structural determination of integrin αIIbβ3 in open state either were restricted to the head region23 or only yielded low resolution structures by electron microscopy of negatively stained protein.15,17,24 While the current understanding of the integrin activation process suggests a substantial conformational change from the inactive to active states, obtaining detailed structural information about these intermediate states is crucial.25,26 In this study, we present the structure of full-length integrin αIIbβ3 derived from platelets, which offers the opportunity to examine the integrin in its native context with physiologically relevant glycosylation. Our structure would provide new insights into the mechanism of integrin activation and its role in thrombosis.
Result
Overall structure of full-length integrin αIIbβ3 in its inactive state
We solved three unique structures of αIIbβ3 induced by different combinations of divalent cations: state A (5 mM Mg2+/1 mM Ca2+); state B (1 mM Mn2+/0.2 mM Ca2+); and state C (1 mM Mn2+/0.2 mM Ca2+), with states B and C co-existing, but separable from cryo-EM data.
In the absence of an exogenous activator, such as RGD peptide or Mn2+,27 purified integrin αIIbβ3 exhibited a bent form, indicating the inactive state (state A) based on the overall features (Fig. 1 and 2, Supplemental Video 1).8 The head and leg region form a sharp angle (~70°) between each other, showing the orientation of the whole extracellular domain and characterizing the bent form of integrin αIIbβ3. The calf-2 domain from αIIb and tail domain from β3 connected to the corresponding single transmembrane helix anchoring on the detergent shell that mimics the cell membrane. The leg region of αIIbβ3 was found to form an angle of approximately 60 degrees to the horizontal direction, suggesting an orientation of αIIbβ3 on the cell surface if the TM helices vertically trans-through membrane. Due to no evidence for a specific orientation before, previous schematic models proposed in papers28,29 depicted a vertically standing integrin with its head region facing the membrane by default. However, our structure showed αIIbβ3 adopted a tilted orientation that consequently would make the head region and the ligand binding site more accessible.
Figure 1. Cryo-EM single-particle reconstruction of inactive integrin αIIbβ3.
A) CryoEM map of αIIbß3 heterodimer. B) The structure of αIIbß3 heterodimer. The structure is composed of αIIb and ß3 molecules. Both integrin molecules within the αIIbß heterodimer, αIIb and ß3, are clearly identifiable and well resolved. All five αIIb domains (ß-propeller, thigh, Calf-1, Calf-2, and TM) and all nine ß3 domains (ßI, Hybrid, PSI, EGF-1,2,3,4, Tail, and TM) are clearly assigned. C) Domain demarcation along the integrin amino acid sequence based on the structural annotation. Each domain was colored differently in the map and structure, with the same color scheme used across all figures in this paper.
Figure 2. Structure of inactive integrin αIIbβ3.
A) Regions of integrin. Based on the domain organization, the whole integrin structure could be split into three regions: Head, Leg, and TM. The integrin stands on the cell membrane in a titled orientation, with a ~70° angle between the Head and Leg regions, and ~60° between the Leg and supposed cell membrane. B) The inset figures show the densities corresponding to the ion binding at MIDAS (Mg2+), ADMIDAS (Ca2+), SyMBS (Ca2+), Asn320 glycosylation and the TM region. (corresponding color in A: red, yellow, purple)
The ion binding pockets including SyMBS (synergistic metal ion-binding site), MIDAS (metal ion-dependent adhesion site), and ADMIDAS (adjacent to MIDAS) residing in the head region are well-resolved in our structure and the coordinated ions could also be identified. (Fig. 2). We also observed in the distal location of the ligand-binding site for the β-propeller, four Ca2+ ions coordinated with adjacent residues to further stabilize the β-sheets, which is in line with previously reported structures(Supplemental Figure. 2).
Since the relative orientation between the TM region and extracellular domain had yet to be determined before this study, excluding some low resolution structures by negative staining,30 the structure resolved here that showed the structural connections between TM region and extracellular domain would help explain how these two domains are involved in the activation process. To deal with the low signal-to-noise ratio (SNR) and TM region flexibility, we employed 3D focus classification. The new map allowed us to effectively sort out particles and successfully resolve two helices from αIIb and β3, as well as the linker region between the Calf-2 domain and the αIIb helix. The two helices adopted a twisted conformation and went across each other forming a clasp at the membrane proximal site. The loop linker between the TM region and whole extracellular domain renders the potential flexibility for the integrin to separate the transmembrane helices in the presence of Mn2+.20
Transition from inactive to a proposed intermediate state
The replacement of Mg2+ with Mn2+ would increase the ligand binding affinity of αIIbβ3 and triggers the activation of αIIbβ3, as deduced from recognition of Mn2+ induced conformation-specific antibodies.27 We used Mn2+ during the purification and determined the αIIbβ3 structure in the presence of Mn2+. We found two new conformations (state B and C) with a particle ratio of 1:1, exhibiting domain movement and a partially opening. The structures were determined at 3.09 Å (state B) and 5.46 Å (state C) resolutions respectively. Previous structural studies of Mn2+ bound integrin in the open state, which were limited to a negative stained TEM result, provided no high resolution details.31 However, we proposed that the two structures obtained in this study would be representing two steps during activation.
Since this new structure in state B cannot be assigned to any known state, we proposed that this state could be an “intermediate state”, compared with the inactive state. Substantial conformational changes between the intermediate and inactive state of αIIbβ3 were found between these two structures. Readily discernible conformational changes and domain movements were found, even though both still adopt a bent orientation. To better elaborate the allosteric changes between these two states, β-propeller domains from inactive and intermediate states were superimposed and resultant relative orientations of other domains were examined (Fig. 3, Supplemental Video 2). Big movements mainly appear at the leg region including the Calf-1 (α-Calf-1) and Calf-2 (α-Calf-2) domains from αIIb, and the EGF-4 (β-EGF-4) and Tail (β-Tail) domain from β3 indicated by the RMSD values for the domains ranging from 2.7 to 8.4 Å (Fig. 3, Supplemental Video 3).
Figure 3. Transition from state A (inactive state) to state B (proposed intermediate state).
Domain shifts between state A and B are shown in the picture. The structure in state B is marked with colors, while the inactive state A is gray. The ß-propeller domain is superimposed to investigate shifts occurring on other domains, and C-alpha RMSD for each pair of domains is reported in the inset table. Regions I,II, and III recapitulate the movements the structure undergoes.
The movements appeared mainly in three regions (I, II, and III in Fig. 3). The region I showed a movement of α1 helix represented by a 2.6 Å shift in backbone at Asp126 from the βI domain, indicating the head region in the β3 molecule underwent a separation from the leg region. The region II has a split effect at the leg region, which is pulling apart the α-Calf-2 and β-Tail domain. Both the α-Calf-2 and β-Tail swing outwards separating the two legs, which is exemplified by the distance between α-Pro778 and β-Asn654 changing from 10.7 Å to 12.7 Å. The region III, mainly located at the β-EGF-4 domain, generated a shift moving away from the β3 head region as well as αIIb leg region. In summary, when integrin αIIbβ3 was treated with Mn2+/Ca2+ instead of Mg2+/Ca2+, αIIbβ3 exhibited domain movement shown as a separation between head region and leg region and thus a potential to open or extend. All three regions of movements happened simultaneously to potentially open the αIIbβ3. Region I, II, and III exhibited the potential to turn the head region, to separate the leg region, and to break the connection between the head and leg regions, respectively. Consequently, TM helices were also separated by the aforementioned movement, making the signal too weak to resolve the individual transmembrane helix in our final structure of this state.
A proposed pre-active form captured after the intermediate form
Given the conformation of the Mn2+ bound integrin αIIbβ3 is highly dynamic, as shown previously21 as well as by this study, we demonstrated both conformations coexist simultaneously in the same ratio. In our study, in addition to the intermediate form of αIIbβ3, another new form was also found during data processing, providing a new view of the molecular mechanism underlying the activation of αIIbβ3 (Fig. 4) in presence of Mn2+.27 Compared to the state B (intermediate state), domain movement and rearrangement became more obvious at regions I, II, and III in state C, indicating this is a resultant or subsequent state after the intermediate state. We proposed state C could be a “pre-active” state between the intermediate and active state.
Figure 4. Transition from state B (proposed intermediate state) to state C (proposed preactive state).
Domain shifts between the state B and C are shown in the picture. The structure and label for state C is marked with colors, while state B is in gray. At regions I and II, α-Calf-2 includes two superimposed states, which shows a turning head region and simultaneous leg region separation. At region III, ßI and the hybrid domains in ß3 are superimposed to demonstrate the ß3 leg region swinging away.
When α-Calf-2 domains from state B and C are superimposed, variations at region I in the head region are the most obvious movement if viewed in the front (Fig. 4). As the β-βI domain separates from leg region, it forms a conformation that significantly turns in the counterclockwise direction (as the same direction shown in Fig. 4), which makes the head region move farther away from the membrane. At region II, the legs were separated wider than all other states (represented by movement of β-EGF4 domain), and interactions between the α-Calf-2 and β-Tail domain could have already been disrupted at this distance (Supplemental Figure 7). In addition, separation between the head and leg region also became more obvious in region III. The leg region, including β-EGF-2, 3, and 4, swung away from and thus formed a bigger angle with the head region. In summary, the pre-active state exhibited a subsequent conformation of the intermediate state reflected by the continuous movement occurring at regions I, II, and III. The resultant effect made the integrin αIIbβ3 undergo both intra-subunit separation (head and leg domain in β3) and inter-subunit separation (leg regions from αIIb and β3).
Discussion
Detergent-solubilized integrin αIIbβ3 has been extensively studied for cryo-EM SPA,32 tomography,33 SANS (Small angle neutron scattering)34 and negative staining EM30,31,35. The activity and conformational change induced by Mn2+ were also validated by antibody-binding and SAXS data,35 which demonstrates that detergent micelle is less likely to restrain the activation of integrin. The detergents used in this study, Triton X-100 and DDM, have been found optimal for stabilization and activity for intact αIIbβ3.35
In this study, we resolve the structure of the integrin αIIbβ3 with the TM region in the inactive state, which indicates the possible orientation of αIIbβ3 in the physiological environment. The leg region is found to form a 60° angle with the supposed cell membrane, which resembles another newly reported full-length integrin αIIbβ3 structure in nanoparticles36(Fig. 5a). When comparing our αIIbβ3 structure solved in detergent with the other structure solved in nanoparticles, we found that the leg region has conformational shift at Calf-2 domain and Tail domain when head region is superimposed (Fig. 5a). In addition, the transmembrane helices from the two structures also adopt two distinct conformations. Unlike the parallel and separate helices found in the nanoparticle structure, the helices in our structure still adopt a “crossing” conformation which is in line with the previous proposed inactive model.37 It is possible that such shifts and different conformations are caused by different approaches employed to stabilize the transmembrane domain, however, it indicates the flexibility of the TM region and how it affects the leg region of integrin.
Figure 5. TM helix orientation and proposed model for activation transition.
A) TM region comparison between the structure of inactive state in this study (indicated by α2b, β3) and full-length structure in nanoparticles (indicated by α2b’, β3’ from PDB: 8T2V). Head region is superimposed and omitted. Orientational difference at TM region and conformational shift at α-Calf-2 and β-tail domain were shown. B) α1 helix movement during activation indicated by comparison with previous reported closed state (gray, PDB:3T3P) and open state (gold, PDB:2VDR)) and intermediate state in this study (cyan). C) Model for activation transition. The state B and C, both of which show the inter- and intra-molecular separation potential, would exist before the active state adopts a fully open form. Main movements start in state B at regions I, II, and III, while continuing through state C. The bent form with separated legs indicates that the leg motion precedes the head lift-up, which explains how the inside out signal transmits.
As previously described, the bent form of integrin would have a breathing motion and may shift the conformational equilibrium from bent state toward an open state.15 The coiled loop linking the extracellular domain and TM region renders the flexibility of the integrin so that the TM helices could have conformational change during activation. In our model, the distance from membrane to the “head” region is around 52.5 Å compared to 24.1 Å showed in previous suggested models,38,39 which adopts similar orientation that found in the in situ study.37 (Supplemental Figure 4) Since the head region, where the RGD-motif binds, is important in terms of ligand-binding, the longer distance to the platelet membrane would make the head region more accessible for the large population of integrin ligand.
As a cell membrane glycoprotein, integrin αIIbβ3 carries several N-glycans in the extracellular domain. However, it remains unclear how the glycans involved in integrin heterodimeric interaction and potential function during activation, it is tempting to speculate the N-glycans would facilitate structural changes during the activation of integrins.40,41 In this study, we extracted the integrin αIIbβ3 directly from platelets to keep the structure close to the physiological state, especially for the glycosylation.39,42,43 Without predictions or partially resolved,15,22,40,44,45 our structure resolves eight glycosylation sites in the intact integrin (Supplemental Figure. 3). We observed a previously proposed but never resolved glycan site Asn931. Extra density was found connected to Asn931 indicating that N-linked glycans are attached to this site (Supplemental Figure 3), though it was formerly predicted as a glycosylation site.40 In addition, we observed the density for glycosylation at Asn320 from β3. Previously resolved structures either identified only two glycans in an ectodomain structure or five glycans in a head region only structure, which made it hard to clearly demonstrate how the glycans of Asn320 participates in the activation of the integrin. In contrast, in our full-length structure, there are five glycan residues that could be seen attached to Asn320. In this structure, we found connecting density between αIIb and β3-Asn320 glycans, and tentatively introduced a water molecule at this position to indicate the potential interactions. (Fig.2b) It is possible that in the context of blood circulation molecules other than water would be more favorable for this position. However, our structure exhibits the potential that the glycans of Asn320 may be involved in the αIIb and β3 interactions. The dimerization of αIIb and β3, which is the prerequisite to becoming a functional unit, is likely to be reinforced by this glycan-induced interaction.
In our study, we also resolved two co-existing structures in the presence of Mn2+, which was proposed to activate the integrin.27,46,47 However, the density of Mn2+ ion is not distinguishable from that of Mg2+ due to the resolution limitation. Instead of an open form of integrin, both forms found in our study adopt the conformation between an inactive and fully active state, which indicated an “intermediate” and “pre-active” state. Previously, structural mapping focused on head piece revealed that eight different steps might exist during the activation process38, demonstrated by the movement of α1 helix. Such proposed activation process, especially the shift that α1 helix undergoes, has yet to be fully validated in full-length integrins. We map our structure in state B to the proposed eight steps and found that it falls into the proposed moving trajectory (approximated to the proposed position 4 or 522, see details in Fig. 5b). One previous study on full-length αIIbβ3 in nanodisc also reveals that it exists in a continuous conformational equilibrium composed by four main states.17 Induced by RGD peptide and Talin, αIIbβ3 would mainly adopt the extended and upright conformation. In contrast, we used Mn2+ to induce the activation and obtained two structures neither of which is in extended conformation. Instead of fully activating the integrin to an extended state, addition of Mn2+ detailed conformational change of head region before extension appears. Through comparison of all three structures solved in our study, we hypothesized they could represent a series of states before the active state (Fig. 5c). When treated with Mn2+, the integrin αIIbβ3 has the potential to be activated, which is hinted by the motion of leg region and head region. A further state may also exist before fully open form, showing a wider separation between the leg region and head region of αIIbβ3.
Upon activation, previous structure of β3-only fragments (contains the headpiece and β-knee regions but lacks the α unit) reported an extended conformation at the I-EGF1/2 junction making the leg almost form a right angle with the head region.23,48 The increment of angle between the head and leg regions is also found in our pre-active structure, however, the angle is not as large as it was in the β3-only structure. Assuming the leg and head region move away from each other from an acute angle to a straight orientation during activation, it is possible the conformation found in our study is an initial activation state prior to the proposed activated state. Since Mn2+ has the potential to trigger the activation of αIIbβ3,47,49–52 the bent form with separated leg region obtained in our study is in line with the previous hypothetical model,22 but provides a substantial and detailed structural basis. We discern two potential conformational states of integrin in the activation process, utilizing a universal Mn2+ activation buffer. However, it is imperative to note that the occurrence of this activation states in the platelet cell membrane (or under other recombinant near-physiological conditions) necessitates further test.
STAR Methods
Resource availability
Lead contact
Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Zhao Wang (zhaow@bcm.edu)
Materials availability
This study did not generate new unique reagents.
Data and code availability
All data are available either in this paper or in the public database. The final maps and models were submitted to the Electron Microscopy Data Bank (EMDB) (accession no. EMD-29931 , no. EMD-29932 and EMD-43046) and PDB (accession no.: 8GCD and 8GCE).
This paper does not report the original code.
Any additional information required to reanalyze the data reported is available from the lead contact upon request.
EXPERIMENTAL MODEL AND STUDY PARTICIPANT DETAILS
Platelet Sample
Human platelets used in this study were obtained from the Gulf Coast Regional Blood Center (Houston, TX, USA).
METHOD DETAILS
Protein extraction and purification
The integrin αIIbβ3 was initially extracted from human platelets obtained from the Gulf Coast Regional Blood Center (Houston, TX, USA). We purified WT full length integrin αIIbβ3 from human platelets by adapting a protocol described previously21. Cells were spun down at 1,200 rpm for 5 min and then resuspended in the CGS buffer (13.4 mM sodium citrate, 33.3 mM dextrose, 123 mM NaCl, pH 7.0) for several rounds until red blood cells were fully removed. The final supernatant was collected and centrifuged at 1200 x g for 30 min, and the resultant platelet pellet was resuspended using a TBS buffer. After several rounds of homogenization using a Dounce B set, the platelet lysis was spun down at 780 x g for 10 min to remove the cell debris followed by another centrifuge at 256,000 x g for 1 hour to collect the cell membrane fraction. The cell membrane fraction was solubilized at 4°C overnight in the 2% (w/v) Triton X-100 supplemented TBS buffer containing 10 mM Tris-HCl pH 7.4, 150 mM NaCl, 5 mM MgCl2, and 1 mM CaCl2. The solubilized membrane protein was collected from the supernatant after centrifugation at 256,000 x g for 1 hour. The supernatant was then applied to concanavalin-A, an affinity column (Con A Sepharose 4B), and eluted with a buffer containing methyl-α-D-mannopyranoside and 0.01%-0.02% (w/v) Triton X-100. Ion exchange chromatography (MonoQ) and size-exclusion chromatography (Superose 6) were completed using a buffer containing 20 mM Hepes, 150 mM NaCl, DDM (2x-4x CMC), 5 mM MgCl2, and 1 mM CaCl2. Peak fraction was collected for the cryoEM specimen preparation (Supplemental Figure 1). For integrin αIIbβ3 in the Mn2+ condition, the buffer was supplemented with 1 mM MnCl2 and 0.2 mM CaCl2 instead of Mg2+/Ca2+, while using the same purification protocols.
CryoEM sample preparation and data collection
For cryo-EM sample preparation, a 3 μl aliquot of purified integrin αIIbβ3 was applied onto a 200-mesh R3.5/1 Quantifoil 2nm-Cfilm grid. After applying the sample, the grid was blotted for 3 s and rapidly frozen in liquid ethane using a Vitrobot IV (FEI), with constant temperature and humidity during the process of blotting. The grid was stored in liquid nitrogen before imaging.
Movie stacks were collected at 300 kV on a Krios electron microscope (FEI) with an in-column energy filter (30 eV width) equipped with a direct electron detector K2 Summit camera (Gatan). Images were collected semi automatically by EPU (Thermo Fisher Scientific) in the dose fractionation super-resolution counting mode at a calibrated physical pixel size of 1.07 Å. The images were collected with a defocus range from −1.0 to −2.6 μm. The total exposure time for the dataset was 7 s, leading to a total accumulated dose of 50 electrons Å2 on the specimen. Each image stack was fractionated into 35 subframes, each with an accumulation time of 0.2 s per frame. The final frame average was computed from averages of every three consecutive frames to correct beam-induced motion during exposure by MotionCor2.53 The image in each frame was weighted according to radiation damage. CTF (Contrast Transfer Function) parameters of the particles in each frame average were determined by the program Patch CTF in cryoSPARC.54
In total, 2,758,651 particle images were automatically boxed out by autopicking in cryoSPARC with a box size of 256 × 256 pixels using an averaged sum of 35 raw frames per specimen area. Two-dimensional (2D) reference-free class averages were computed using cryoSPARC. Initial models for every reconstruction were generated from scratch using selected good quality 2D averages with C1 symmetry based on the 2D averaged results. This initial model was low-pass–filtered to 60 Å, and refinements were carried out using cryoSPARC. After several rounds of homogeneous refinement and local refinement, the resolution achieved 3 A but with a weak signal in the TM region. To improve the quality of the TM region, aligned particles were transferred to RELION55 for further processing. To deal with the low signal-to-noise ratio (SNR) and flexibility of the TM region, we employed 3D focus classification to further sort out particles. A spherical mask was created focusing on the TM region and applied to the 3D classification in RELION (Supplemental Figure 5). The final map was constructed by the combination of the extracellular domain and TM region.
For the map in the Mn2+ condition, the cryoSPARC processing workflow is similar to that for native structure (Supplemental Figure 6). In total, 1,701,301 particles were obtained after iterative 2D classification, and ~10% of particles were used for the initial model reconstruction. Each conformation was obtained from subclasses in the same Mn2+ dataset, and corresponding particles were separated for further processing. Two maps showing significant differences were obtained with the particle ratio 1:1.02. For state C, the EM map was refined to a proper resolution where domain information could be seen, while details for the secondary structure were still missing (Fig. 4). Individual domain from integrin αIIbβ3 was rigid-docking in the density. After individual refinement for each particle set, the two maps were finally refined to 3.09Å and 5.46 Å respectfully.
Cryo-EM model building and refinement
We started model building for full-length inactive integrin αIIbβ3 by docking the extracellular domain (PDBID:3FCS)15 and TM region (PDBID:2KNC).37 The model was refined against the corresponding map using PHENIX56 in real space with the secondary structure and geometry restraints. Since the EM density map is not confidently resolvable for every amino acid at the leg and TM regions due to the flexibility, we carried out rigid fitting of structures of the Calf-2 domain from αIIb, the Tail domain from β3, and the TM region. We used previously published TM region structure determined by Nuclear Magnetic Resonance (NMR) (2KNC) to build these parts of the model, instead of utilizing real-space refinement. The model was then manually refined and adjusted in Coot.57 The model quality was validated using PHENIX and the local resolution was estimated using cryoSPARC. The aforementioned workflow applied to structure refinement in the inactive form and intermediate form, while the pre-active form was only applied with the rigid body-fitting for each domain due to low resolution.
QUANTIFICATION AND STATISTICAL ANALYSIS
Cryo-EM data collection and refinement statistics are shown in Table S1.
Supplementary Material
Supplemental Video 1: The structure of integrin αIIbβ3 in inactive state. Related to Figure 1–2.
Supplemental Video 2: The structure of integrin αIIbβ3 in intermediate state. Related to Figure 3.
Supplemental Video 3: The conformational change and simulated domain movement between inactive state and intermediate state. Related to Figure 4–5
REAGENT or RESOURCE | SOURCE | IDENTIFIER |
---|---|---|
Biological samples | ||
Human platelets | Gulf Coast Regional Blood Center (Houston, TX, USA) | N/A |
Chemicals, peptides, and recombinant proteins | ||
Sodium citrate | Sigma Aldrich | Catalog Number: 71402 |
Dextrose | Sigma Aldrich | Catalog Number: G7879 |
Sodium chloride | Sigma Aldrich | Catalog Number: S6546 |
Triton X-100 | Sigma Aldrich | Catalog Number: T8787 |
Tris-HCl | Fisher Scientific | Catalog Number: 15-567-027 |
MgCl2 | Sigma Aldrich | Catalog Number: 68475 |
CaCl2 | Fisher Scientific | Catalog Number: C79-500 |
DDM | Anatrace | Catalog Number: D310S |
MnCl2 | Thermo Fisher | Catalog Number: 011563-36 |
Hepes | Sigma Aldrich | Catalog Number: 83264-500ML-F |
Deposited data | ||
Inactive αIIbβ3 EM Map | This manuscript | EMDB- 29931 |
Intermediate αIIbβ3 EM Map | This manuscript | EMDB- 29932 |
Inactive αIIbβ3 Model | This manuscript | PDB- 8GCD |
Intermediate αIIbβ3 Model | This manuscript | PDB- 8GCE |
Pre-active αIIbβ3 EM Map | This manuscript | EMD-43046 |
Software and algorithms | ||
cryoSPARC | Ali Punjani et al.54 | https://guide.cryosparc.com/ |
Relion | Sjors Scheres et al.55 | https://relion.readthedocs.io/en/release-5.0/ |
PHENIX | Afonine, P. V. et al.56 | https://phenix-online.org/ |
COOT | Emsley, P et al.57 | https://www2.mrc-lmb.cam.ac.uk/ |
Other | ||
Con A Sepharose 4B column | Sigma Aldrich | Catalog Number: GE17-0440-03 |
MonoQ column | Cytiva | Catalog Number: 17115301 |
Superose 6 column | Cytiva | Catalog Number: 29091596 |
Highlights.
Cryo-EM structures of full-length integrin αIIbβ3 purified from human platelets
Three integrin αIIbβ3 states are revealed that are involved in the activation process
Allosteric structural variations are likely important for the activation mechanism
Acknowledgement:
We thank Drs. Guizhen Fan, Xinzhe Yu, Joshua I Rosario Sepulveda, Steve Ludtke, Theodore Wensel and Timothy Springer for suggestions and comments on the experiment and manuscript. This work is supported by (R01GM143380 and R01HL162842, and the Welch Foundation Q-2173-20230405) BCM BMB department seed funds to Z..W. CryoEM data was collected at the Baylor College of Medicine CryoEM core and UThealth cryoEM core, which includes equipment purchased under support of CPRIT Core Facility Award RP190602.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Declaration of Interests
The authors declare no competing interests.
Reference
- 1.Bennett JS (2017). αIIbβ3 (GPIIb/IIIa) Structure and Function. In Platelets in Thrombotic and Non-Thrombotic Disorders, Gresele P, Kleiman NS, Lopez JA, and Page CP, eds. (Springer International Publishing; ), pp. 99–112. 10.1007/978-3-319-47462-5_8. [DOI] [Google Scholar]
- 2.Portier I, and Campbell RA (2020). Role of Platelets in Detection and Regulation of Infection. Arterioscler. Thromb. Vasc. Biol 10.1161/ATVBAHA.120.314645. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Ruggeri ZM, and Mendolicchio GL (2007). Adhesion Mechanisms in Platelet Function. Circ. Res 100, 1673–1685. 10.1161/01.RES.0000267878.97021.ab. [DOI] [PubMed] [Google Scholar]
- 4.Thomas SG (2019). The Structure of Resting and Activated Platelets. In Platelets (Elsevier; ), pp. 47–77. 10.1016/B978-0-12-813456-6.00003-5. [DOI] [Google Scholar]
- 5.Ill CR, Engvall E, and Ruoslahti E (1984). Adhesion of platelets to laminin in the absence of activation. J. Cell Biol 99, 2140–2145. 10.1083/jcb.99.6.2140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Sonnenberg A, Modderman PW, and Hogervorst F (1988). Laminin receptor on platelets is the integrin VLA-6. Nature 336, 487–489. 10.1038/336487a0. [DOI] [PubMed] [Google Scholar]
- 7.Hynes RO (2002). Integrins. Cell 110, 673–687. 10.1016/S0092-8674(02)00971-6. [DOI] [PubMed] [Google Scholar]
- 8.Hood JD, and Cheresh DA (2002). Role of integrins in cell invasion and migration. Nat. Rev. Cancer 2, 91–100. 10.1038/nrc727. [DOI] [PubMed] [Google Scholar]
- 9.Campbell ID, and Humphries MJ (2011). Integrin Structure, Activation, and Interactions. Cold Spring Harb. Perspect. Biol 3, a004994. 10.1101/cshperspect.a004994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Ruoslahti E. (1996). RGD AND OTHER RECOGNITION SEQUENCES FOR INTEGRINS. Annu. Rev. Cell Dev. Biol 12, 697–715. 10.1146/annurev.cellbio.12.1.697. [DOI] [PubMed] [Google Scholar]
- 11.Qin J, Vinogradova O, and Plow EF (2004). Integrin Bidirectional Signaling: A Molecular View. PLoS Biol. 2, e169. 10.1371/journal.pbio.0020169. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Shattil SJ, Kim C, and Ginsberg MH (2010). The final steps of integrin activation: the end game. Nat. Rev. Mol. Cell Biol 11, 288–300. 10.1038/nrm2871. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Xiong J-P, Stehle T, Diefenbach B, Zhang R, Dunker R, Scott DL, Joachimiak A, Goodman SL, and Arnaout MA (2001). Crystal Structure of the Extracellular Segment of Integrin αVβ3. Science 294, 339–345. 10.1126/science.1064535. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Xiong J-P, Stehle T, Zhang R, Joachimiak A, Freeh M, Goodman SL, and Arnaout MA (2002). Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand. Science 296, 151–155. 10.1126/science.1069040. [DOI] [PubMed] [Google Scholar]
- 15.Zhu J, Luo B-H, Xiao T, Zhang C, Nishida N, and Springer TA (2008). Structure of a complete integrin ectodomain in a physiologic resting state and activation and deactivation by applied forces. Mol. Cell 32, 849–861. 10.1016/j.molcel.2008.11.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Xie C, Zhu J, Chen X, Mi L, Nishida N, and Springer TA (2010). Structure of an integrin with an αI domain, complement receptor type 4. EMBO J. 29, 666–679. 10.1038/emboj.2009.367. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Xu X-P, Kim E, Swift M, Smith JW, Volkmann N, and Hanein D (2016). Three-Dimensional Structures of Full-Length, Membrane-Embedded Human αIIbβ3 Integrin Complexes. Biophys. J 110, 798–809. 10.1016/j.bpj.2016.01.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Chen J, Salas A, and Springer TA (2003). Bistable regulation of integrin adhesiveness by a bipolar metal ion cluster. Nat. Struct. Mol. Biol 10, 995–1001. 10.1038/nsb1011. [DOI] [PubMed] [Google Scholar]
- 19.Zhu J, Carman CV, Kim M, Shimaoka M, Springer TA, and Luo B-H (2007). Requirement of alpha and beta subunit transmembrane helix separation for integrin outside-in signaling. Blood 110, 2475–2483. 10.1182/blood-2007-03-080077. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Fong KP, Zhu H, Span LM, Moore DT, Yoon K, Tamura R, Yin H, DeGrado WF, and Bennett JS (2016). Directly Activating the Integrin αIIbβ3 Initiates Outside-In Signaling by Causing αIIbβ3 Clustering. J. Biol. Chem 291, 11706–11716. 10.1074/jbc.M116.716613. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Eng ET, Smagghe BJ, Walz T, and Springer TA (2011). Intact αIIbβ3 Integrin Is Extended after Activation as Measured by Solution X-ray Scattering and Electron Microscopy. J. Biol. Chem 286, 35218–35226. 10.1074/jbc.M111.275107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Zhu J, Zhu J, and Springer TA (2013). Complete integrin headpiece opening in eight steps. J. Cell Biol 201, 1053–1068. 10.1083/jcb.201212037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Zhou D, Thinn AMM, Zhao Y, Wang Z, and Zhu J (2018). Structure of an extended β3 integrin. Blood 132, 962–972. 10.1182/blood-2018-01-829572. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Dai A, Ye F, Taylor DW, Hu G, Ginsberg MH, and Taylor KA (2015). The Structure of a Full-length Membrane-embedded Integrin Bound to a Physiological Ligand. J. Biol. Chem 290, 27168–27175. 10.1074/jbc.M115.682377. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Li J, and Springer TA (2017). Integrin extension enables ultrasensitive regulation by cytoskeletal force. Proc. Natl. Acad. Sci. U. S. A 114, 4685–4690. 10.1073/pnas.1704171114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Nešić D, Zhang Y, Spasic A, Li J, Provasi D, Filizola M, Walz T, and Coller BS (2020). Cryo-Electron Microscopy Structure of the αIIbβ3-Abciximab Complex. Arterioscler. Thromb. Vasc. Biol 40, 624–637. 10.1161/ATVBAHA.119.313671. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Ni H, Li A, Simonsen N, and Wilkins JA (1998). Integrin Activation by Dithiothreitol or Mn2+ Induces a Ligand-occupied Conformation and Exposure of a Novel NH2- terminal Regulatory Site on the β1Integrin Chain. J. Biol. Chem 273, 7981–7987. 10.1074/jbc.273.14.7981. [DOI] [PubMed] [Google Scholar]
- 28.Luo B-H, and Springer TA (2006). Integrin structures and conformational signaling. Curr. Opin. Cell Biol 18, 579–586. 10.1016/j.ceb.2006.08.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Bledzka K, Smyth SS, and Plow EF (2013). Integrin αIIbβ3. Circ. Res 112, 1189–1200. 10.1161/CIRCRESAHA.112.300570. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Choi W-S, Rice WJ, Stokes DL, and Coller BS (2013). Three-dimensional reconstruction of intact human integrin αIIbβ3: new implications for activation-dependent ligand binding. Blood 122, 4165–4171. 10.1182/blood-2013-04-499194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Sen M, Koksal AC, Yuki K, Wang J, and Springer TA (2018). Ligand- and cation-induced structural alterations of the leukocyte integrin LFA-1. J. Biol. Chem 293, 6565–6577. 10.1074/jbc.RA117.000710. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Adair BD, and Yeager M (2002). Three-dimensional model of the human platelet integrin αIIbβ3 based on electron cryomicroscopy and x-ray crystallography. Proc. Natl. Acad. Sci 99, 14059–14064. 10.1073/pnas.212498199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Iwasaki K, Mitsuoka K, Fujiyoshi Y, Fujisawa Y, Kikuchi M, Sekiguchi K, and Yamada T (2005). Electron tomography reveals diverse conformations of integrin alphaIIbbeta3 in the active state. J. Struct. Biol 150, 259–267. 10.1016/j.jsb.2005.03.005. [DOI] [PubMed] [Google Scholar]
- 34.Nogales A, García C, Pérez J, Callow P, Ezquerra TA, and González-Rodríguez J (2010). Three-dimensional model of human platelet integrin alphaIIb beta3 in solution obtained by small angle neutron scattering. J. Biol. Chem 285, 1023–1031. 10.1074/jbc.M109.050039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Eng ET, Smagghe BJ, Walz T, and Springer TA (2011). Intact alphaIIbbeta3 integrin is extended after activation as measured by solution X-ray scattering and electron microscopy. J. Biol. Chem 286, 35218–35226. 10.1074/jbc.M111.275107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Adair BD, Xiong J-P, Yeager M, and Arnaout MA (2023). Cryo-EM structures of full-length integrin αIIbβ3 in native lipids. Nat. Commun 14, 4168. 10.1038/s41467-023-39763-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Yang J, Ma Y-Q, Page RC, Misra S, Plow EF, and Qin J (2009). Structure of an integrin αIIbβ3 transmembrane-cytoplasmic heterocomplex provides insight into integrin activation. Proc. Natl. Acad. Sci 106, 17729–17734. 10.1073/pnas.0909589106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Chigaev A, Buranda T, Dwyer DC, Prossnitz ER, and Sklar LA (2003). FRET Detection of Cellular α4-Integrin Conformational Activation. Biophys. J 85, 3951–3962. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Sun G, Guillon E, and Holley SA (2021). Integrin intra-heterodimer affinity inversely correlates with integrin activatability. Cell Rep. 35, 109230. 10.1016/j.celrep.2021.109230. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Cai X, Thinn AMM, Wang Z, Shan H, and Zhu J (2017). The importance of N-glycosylation on α3 integrin ligand binding and conformational regulation. Sci. Rep 7, 4656. 10.1038/S41598-017-04844-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Li J, Su Y, Xia W, Qin Y, Humphries MJ, Vestweber D, Cabañas C, Lu C, and Springer TA (2017). Conformational equilibria and intrinsic affinities define integrin activation. EMBO J. 36, 629–645. 10.15252/embj.201695803. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Stephens PE, Ortlepp S, Perkins VC, Robinson MK, and Kirby H (2000). Expression of a Soluble Functional Form of the Integrin α4β1 in Mammalian Cells. Cell Adhes. Commun 7, 377–390. 10.3109/15419060009109020. [DOI] [PubMed] [Google Scholar]
- 43.Takada Y, Elices MJ, Crouse C, and Hemler ME (1989). The primary structure of the alpha 4 subunit of VLA-4: homology to other integrins and a possible cell-cell adhesion function. EMBO J. 8, 1361–1368. 10.1002/j.1460-2075.1989.tb03516.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Xiao T, Takagi J, Coller BS, Wang J-H, and Springer TA (2004). Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature 432, 59–67. 10.1038/nature02976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Zhu J, Zhu J, Negri A, Provasi D, Filizola M, Coller BS, and Springer TA (2010). Closed headpiece of integrin αIIbα3 and its complex with an αIIbα3-specific antagonist that does not induce opening. Blood 116, 5050–5059. 10.1182/blood-2010-04-281154. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Cluzel C, Saltel F, Lussi J, Paulhe F, Imhof BA, and Wehrle-Haller B (2005). The mechanisms and dynamics of αvβ3 integrin clustering in living cells. J. Cell Biol 171, 383–392. 10.1083/jcb.200503017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Ye F, Kim C, and Ginsberg MH (2012). Reconstruction of integrin activation. Blood 119, 26–33. 10.1182/blood-2011-04-292128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Thinn AMM, Wang Z, Zhou D, Zhao Y, Curtis BR, and Zhu J (2018). Autonomous conformational regulation of β3 integrin and the conformation-dependent property of HPA-1a alloantibodies. Proc. Natl. Acad. Sci 115, E9105–E9114. 10.1073/pnas.1806205115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Schumacher S, Dedden D, Nunez RV, Matoba K, Takagi J, Biertümpfel C, and Mizuno N (2021). Structural insights into integrin α 5 β 1 opening by fibronectin ligand. Sci. Adv 7, eabe9716. 10.1126/sciadv.abe9716. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Takagi J, Petre BM, Walz T, and Springer TA (2002). Global Conformational Rearrangements in Integrin Extracellular Domains in Outside-In and Inside-Out Signaling. Cell 110, 599–611. 10.1016/S0092-8674(02)00935-2. [DOI] [PubMed] [Google Scholar]
- 51.Ye F, Liu J, Winkler H, and Taylor KA (2008). Integrin αIIbβ3 in a Membrane Environment Remains the Same Height after Mn2+ Activation when Observed by Cryoelectron Tomography. J. Mol. Biol 378, 976–986. 10.1016/j.jmb.2008.03.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Kim M, Carman CV, and Springer TA (2003). Bidirectional Transmembrane Signaling by Cytoplasmic Domain Separation in Integrins. Science 301, 1720–1725. 10.1126/science.1084174. [DOI] [PubMed] [Google Scholar]
- 53.Zheng SQ, Palovcak E, Armache J-P, Verba KA, Cheng Y, and Agard DA (2017). MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331–332. 10.1038/nmeth.4193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Punjani A, Rubinstein JL, Fleet DJ, and Brubaker MA (2017). cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296. 10.1038/nmeth.4169. [DOI] [PubMed] [Google Scholar]
- 55.Scheres SHW (2012). RELION: Implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol 180, 519–530. 10.1016/j.jsb.2012.09.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Afonine PV, Poon BK, Read RJ, Sobolev OV, Terwilliger TC, Urzhumtsev A, and Adams PD (2018). Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. Sect. Struct. Biol 74, 531–544. 10.1107/S2059798318006551. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Emsley P, Lohkamp B, Scott WG, and Cowtan K (2010). Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr 66, 486–501. 10.1107/S0907444910007493. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supplemental Video 1: The structure of integrin αIIbβ3 in inactive state. Related to Figure 1–2.
Supplemental Video 2: The structure of integrin αIIbβ3 in intermediate state. Related to Figure 3.
Supplemental Video 3: The conformational change and simulated domain movement between inactive state and intermediate state. Related to Figure 4–5
Data Availability Statement
All data are available either in this paper or in the public database. The final maps and models were submitted to the Electron Microscopy Data Bank (EMDB) (accession no. EMD-29931 , no. EMD-29932 and EMD-43046) and PDB (accession no.: 8GCD and 8GCE).
This paper does not report the original code.
Any additional information required to reanalyze the data reported is available from the lead contact upon request.